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Abstract
Background: Tamoxifen (TX) is widely used for the treatment of male factor and
idiopathic infertility. It has been shown that TX induces sperm production and so
improves male fertility.
Objective: This study evaluated the effects of different doses of TX on the sperm
parameters and chromatin quality in mice.
Materials and Methods: In this research, 24 male NMRI mice were divided into three
groups including groupA: control animal receiving vehicle; groupB: the group receiving
basal diet and TX 0.4 mg/kg/day; and group C: the group receiving basal diet and
TX 0.6 mg/kg/day for 35 days. Thereafter, epididymal spermatozoa were analyzed
for standard parameters and nuclear chromatin quality using Aniline Blue (AB) and
Toluidine Blue (TB) staining.
Results: The results indicated that although the TX did not affect the sperm count,
motility, and viability parameters, it could elevate the percentage of sperm cells
with abnormal morphology and abnormal chromatin at both doses. In addition, in
comparison with the control mice, a significant elevation was observed in spermatozoa
with residual histones (assessed by AB staining) at high doses of TX.
Conclusion: Our experimental data in mice suggested that the use of TX for treating
male infertility might increase the rates of spermatozoa with abnormal chromatin in a
dose-dependent manner.
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1. Introduction
Male and female infertility is a common problem
with 10–15% of couples being infertile, 50% of
which are male factor (1). On the other hand,
more than 30% of male infertility is unexplained
(2) and about 10% of these men have azoosper-
mia. Tamoxifen (TX) lies in selective anti-estrogen
receptor modulators (SERM) drug category. It has
been used in the treatment of infertile men with
idiopathic infertility, oligospermia, and nonobstruc-
tive azoospermia (3). Daily use of 20 mg TX in
men with sexual dysfunction for six consecutive
months increased the sperm count in the ejac-
ulate (4). One study indicated that anti-estrogen
drugs such as TX could improve the results of
spermatogenesis in testicular samples in men with
non-obstructive ozoospermia where TX was used
for three consecutive months. In addition, the use
of this drug has a positive effect on patients with
sperm maturation, so taking TX can increase the
probability of pregnancy throughmicroinjection (3).
Today, the detection of sperm nuclear chromatin
integrity is a very important issue in male fertility
assessments (5). The sperm chromatin is highly
structured that contains DNA and heterogeneous
nucleoproteins. The dense and insoluble nature
of sperm chromatin protects the genetic material
of the cell while passing through the male and
female genital tract (6). The results of another study
suggested that in varicocele patients, there is a
high rate of spermatozoa with abnormal chromatin
condensation, which is one of the possible causes
of male infertility due to varicocele (7).
Our present study aims to investigate the pos-
sible effects of TX on sperm parameters and
chromatin condensation. Although TX is now used
as a therapeutic drug for infertile men to increase
sperm count, we investigated the effect of TX on
the sperm chromatin quality and its condensa-
tion, which is a new issue in male reproductive
evaluations. On the other hand, we proposed the
safe dosage of TX to reduce the damage of
spermatozoa caused by this drug. Therefore, the
different doses and the chromatin assessments are
the novelties of the present study.
2. Materials and Methods
2.1. Animals
In this experimental study, 24 adult male NMRI
mice weighing 30–35 gr were divided into three
groups including two experimental (B: dose 0.4
mg/kg/day and C: dose 0.6 mg/kg/day) and one
control (C) groups, each containing eight mice. The
animals of group B received basal diet and TX (low
dose) orally, group C received basal diet and TX
(high dose :), and group A as the control animals
received basal diet without any treatments for 35
days. All mice were maintained at a temperature of
22–23°C, the humidity of 50–55%, and a light/dark
cycle of 14/10 hr.
2.2. Tamoxifen (TX) treatment
The animals in the two experimental groups B
and C were orally administrated 0.4 mg/kg/day
and 0.6 mg/kg/day of TX (Iran Hormone Co.),
respectively. To prepare the drug dosages, the 10
mg pills of TX were suspended uniformly in water
by sonication and then administrated daily using a
mice-feeding tube.
2.3. Epididymal sperm aspiration and
sperm analysis
At the end of day 35, the mice were killed
through cervical dislocation and the tail of right
epididymis of each mouse was intercept and
placed in 1 ml of pre-warmed Ham’s F10 medium.
The dishes were placed in the incubator (37°C)
for 15 min. Swim-out spermatozoa were used to
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calculate and determine the count, motility, mor-
phology, and viability. Motility was determined in
three categories including progressive (fast and
slow), non-progressive, and immotile spermatozoa.
Spermmorphology was assessed by Papanicolaou
staining and the percentage of sperm cells with
normal morphology was determined. For viability,
we used Eosin test where 200 spermatozoa were
counted (8, 9).
2.4. Sperm chromatin assays
For evaluating the sperm chromatin conden-
sation, we used cytochemical methods including
Aniline Blue (AB) and Toluidine Blue (TB) stainings
(7). All dyes and chemicals were purchased from
Sigma Aldrich Company (St Louis, MO, USA).
2.4.1. Aniline blue (AB) staining
Nuclear histones with a large number of basic
amino acids like Lysine react with acidic dyes such
as AB. Spermatozoa with blue-stained nuclei are
considered as immature spermatozoa (AB+) which
have excessive histones, while colorless spermato-
zoa are considered as normal or mature spermato-
zoa (AB-). For this staining, air-dried smears were
fixed in 3% buffered glutaraldehyde in phosphate
buffer 0.2 M (pH = 7.2) for 30 min at room tempera-
ture, and then they were stained with aqueous AB
5% stain in acetic acid 4% (pH = 3.5) for 7 min. In
each slide, 200 sperm cells were counted and the
percentages of AB+ and AB- were determined (10).
2.4.2. Toluidine blue (TB) staining
Toluidine blue is a metachromatic color, which
establishes both chromatin condensation and DNA
fragmentation via connection to phosphate groups
of DNA molecules (8). To do this staining, air-
dried smears were fixed in fresh ethanol-acetone
96% (1:1) at 4°C for 30 min, and then hydrolyzed
in HCl 0.1 N at 4°C for 5 min. Next, the sperm
smears were washed three times in distilled water
for 2 min, subsequently, TB staining were done
0.05% in citrate phosphate 50% for 10 min at
room temperature. In each slide, 200 spermatozoa
were counted under light microscopy using ×100
eyepiece magnifications (7, 10). In TB staining, the
sperm cells were scored by the color of heads with
score 0: light blue (good chromatin); 1: dark blue
(mild abnormal chromatin); 2: violet; and 3: purple
(severe chromatin abnormality). So, scores 1, 2,
and 3 represent TB+ or sperm cells with abnormal
chromatin.
2.5. Ethical consideration
Animal usage and the protocols were approved
by the Institutional Animal Care and Ethics Com-
mittee of Biological Sciences of Yazd University
(IR.SSU.MEDICINE.REC.1395.9).
2.6. Statistical analysis
The results were introduced into SPSS software
(Statistical Package for the Social Sciences, version
18.0, SPSS Inc., Chicago, Illinois, USA). The statisti-
cal analysis was performed to compare the groups
by one-way ANOVA and compare between groups
by the post hoc-Tukey analysis. In all analyses, p <
0.05 was considered as statistically significant.
3. Results
Considering the effects of TX on sperm counts,
viability, and motility, no significant differences
were observed between the groups, but it can
increase the percentage of sperm cells with
abnormal morphology. Indeed, the percentage of
sperm with an abnormal morphology was higher
in groups B and C than in group A (Figure 1).
There was no significant difference between B
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and C groups. However, in the chromatin study,
the AB staining showed a statistically significant
difference only at a high dose (group C) (Figure
2). In addition, concerning TB staining, there was
a significant difference between both doses B
and C with group A (Figure 3), but there was no
significant difference between groups B and C
(Table I).
Table I. The results of sperm analysis in the two experimental groups: dose 0.6 mg/kg/day (C), dose 0/4 mg/kg/day (B), and control
group (A)





Count 42.7 ± 4.6 43.8 ± 6.3 43.2 ± 5.3 0.919
Fast, slow motility (%) (grade a-b) 60.2 ± 5.3 60.6 ± 4.9 61.8 ± 3.9 0.778
Non progressive motility (%) (grade c) 13.0 ± 5.07 13.7 ± 4.2 17.1 ± 7.5 0.336
Immotile motility (%) (grade d) 25.6 ± 4.5 25.6 ± 6.1 21.0 ± 9.0 0.317
Viability (%) 62.8 ± 2.9 61.7 ± 12.6 64.8 ± 3.5 0.721
Normal morphology (%) 68.5 ± 12.6 54.7 ± 6.0* 54.1 ± 7.7* 0.008
AB 16.0 ± 4.9 19.1 ± 1.5 25.7 ± 4.9# 0.000
TB 6.7 ± 1.4 12.6 ± 5.7* 13.1 ± 1.1* 0.002
Note: The results are shown as mean ± SD, p < 0.05. For data analysis, we used standard one-way ANOVA test
Parameters and AB: Aniline blue, TB: Toluidine blue
“*”Significant difference between the control group and the two experimental groups considering the morphology sperm
and TB staining
“#”Significantly different between the control group and group C on AB staining
Figure 1. Morphological abnormalities of sperrms ; the arrow indicates abnormal spermatozoon. Papanicolaou staining
(magnification 100×).
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Figure 2. Two Aniline blue-reacted sperms (AB+) and one normal sperm cell (AB-); Aniline blue staining (magnification 100×).
Figure 3. Toluidine blue staining of sperms; TB+ indicates sperm cells with abnormal chromatin and TB- indicates sperm cells with
normal chromatin (magnification 100×).
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4. Discussion
The findings of the present study suggested that
taking different doses of TX does not affect the
parameter, but it weakens sperm morphology and
quality of chromatin. It has been found that TX
may increase sperm count and today it is used
as a good therapeutic way in the treatment of
male-factor infertility. There are several clinical and
experimental studies indicating the effects of TX on
non-obstructive azoospermia (3, 4). Although there
are many data on the relationship between TX and
sperm parameters, our report may be considered
as a novel work representing the side effects of
TX on chromatin sperm. In one study conducted on
the beneficial effects of TX on sperm improvement
in infertile men with non-obstructive azoospermia,
the elevated sperm count was observed in the
azoospermia and maturation syndrome groups
(3). The use of TX enhances the thickness of
the tunica albuginea and shrinks the diameter
and thickness of the seminiferous tubules. There
was also a significant reduction in the number
of spermatogonial cells including spermatogonia
types A and B, primary spermatocytes, sperma-
toids, spermatozoa, Sertoli, and Leydig cells (11).
Another study in 2005 revealed that TX did not
have any effect on sperm count at a dose of 0.4
mg/kg/day for 60 days (12). Similarly, in our study,
the use of this drug had no effect on the number
of epididymal sperm at a dose of 0.4 and 0.6
mg/kg/day for 35 days. In contrast, a study in 2007
showed that the treatment of patients with the
dose of 0.4 mg/kg/day TX significantly reduced the
sperm concentration and motility in ejaculated and
epididymal spermatozoa; but it did not affect sperm
survival rates (13). In our study, TX had a negative
effect on sperm chromatin quality, which can lead
to negative effects on fertility. Another experimen-
tal study in 2004 indicated that TX citrate has
a negative effect on the testicular and prostatic
size and decreases the level of testosterone in
dogs (14). Recent studies have shown that the
use of TX drug on sperm structure and oxidative
stress levels in oligoasthenoteratospermic patients
can significantly improve malondialdehyde, sperm
concentration, sperm morphology, pathology, and
mitochondrial abnormalities (15). The use of estro-
gen antagonist drugs such as TX can improve
infertility in sperm count in infertile patients with
less side effects (16). On the other hand, our results
determined some anomalies in sperm chromatin,
which are observed following TX administration. It
has been found that high percentages of sperm
protamine defects could be an important cause for
idiopathic abortion (17).
A study in 2009 suggested that another side
effect of TX therapy may be a significant reduc-
tion of DNA methylation (IGF2-H19ICR) in region-
specific DNA methylation in rat spermatozoa, but
overall, the total methylation level is not altered.
The spermatozoa DNA methylation (IGF2-H19ICR)
of specific DNA methylation in rat spermatozoa
may affect fetal viability after implantation (18). A
study performed in 2002 demonstrated that TX
treatment could cause pre-implantation embryo
loss at the 2-4-cell stage and post-implantation
embryo loss at around days 8-9 of gestation. One of
the possible mechanism of the effects of TX on the
fetus is reducing androgens and blocking estrogen
receptors (19). In addition, another study suggested
that TX citrate reduces sperm chromosomal con-
densation via reducing the testicular levels of the
transition proteins 1, 2 (TP1, TP2), protamine 1 (P1),
and cyclic adenosine 3’, 5’ monophosphate (AMP)
response element modulator-τ (CREM) proteins
which play an important role in chromatin com-
paction during spermatogenesis. It is believed that
TX citrate has an effect on the expression of these
genes at both levels including transcriptional and
post-translational levels (12). Our study can open
a new avenue for broader research to determine
the positive and negative effects of TX drug use
on the quality of chromatin. Our study limitations
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include the problems related to mice death and
small sample size.
5. Conclusion
Our results suggested that the use of TX at
different doses could not affect the sperm param-
eters (count-viability-motility) in one duration of
spermatogenesis. In addition, TX increases sperm
with abnormal morphology and may diminish the
quality of sperm chromatin at both doses by a
reduction in chromatin compaction which is very
important in male fertility and embryonic develop-
ment. Therefore, in the therapeutic usage of TX, we
should consider the detrimental effects of this drug
on the sperm chromatin structure.
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